You are here: Industry Insights > IgAN

News List

Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin® Ligand Discovery Using Cutting-Edge AI and Molecular Modeling Techniques B3C newswire
November 06, 2023
We are excited to announce a pioneering partnership between Nostrum Biodiscovery, a frontrunner in computational molecular engineering services, and Navigo Proteins, an innovator developing next generation targeting ligands called Affilin®.
Cellvera Receives $20M Order for COVID-19 Oral Antiviral Avigan contractpharma
January 25, 2022
Favipiravir is a broad-spectrum oral antiviral drug that targets COVID-19 and 11 other infectious diseases.
Ligand Partner Jazz Pharmaceuticals Launches RYLAZE (asparaginase erwinia chrysanthemi (recombinant)-rywn), Formerly JZP458 firstwordpharma
July 22, 2021
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has launched Rylaze™(asparaginase erwinia chrysanthemi (recombinant)-rywn), also known as JZP458.
Ligand Pharmaceuticals Appoints Jennifer Cochran to its Board of Directors firstwordpharma
July 15, 2021
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) ("Ligand" or "the Company")announces the appointment of Jennifer Cochran, Ph.D. to the Company's Board of Directors
Novartis’ radioligand therapy granted US Breakthrough Therapy Designation pharmatimes
June 22, 2021
Swiss pharma company Novartis has scored a Breakthrough Therapy Designation (BTD) from the US Food and Drug Administration for its investigational radioligand therapy Lu-PSMA-617.
Gossamer Bio Appoints Sandra Milligan to its Board of Directors firstwordpharma
June 15, 2021
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics today announced the appointment of Sandra Milligan, M.D., J.D., to its Board of Directors.
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement prnasia
June 03, 2021
GenScript Biotech Corporation along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated announced that they have entered into a strategic licensing agreement for Ligand's OmniAb® Platform, a multi-species antibody discovery ...
Novartis expands targeted radioligand therapy pipeline with in-license for compounds targeting Fibroblast Activation Protein (FAP) americanpharmaceuticalreview
April 07, 2021
Novartis has obtained exclusive worldwide rights to develop and commercialize therapeutic applications for a library of Fibroblast Activation Protein (FAP) targeting agents including FAPI-46 and FAPI-74, through an assignment agreement with ...
Dr. Reddy's and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies prnasia
January 28, 2021
Dr. Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) today announced results from an Avigan study on moderate-severe hospitalized COVID-19 patients in Kuwait.
Piramal Pharma Solutions invests ~$32 mn in its Riverview Michigan facility expresspharma
December 10, 2020
Piramal Pharma’s Pharma Solutions business announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of active pharma ingredients (APIs).